Cargando…

Production and applications of fluorobody from redox-engineered Escherichia coli

ABSTRACT: Efficient selection and production of antibody fragments in microbial systems remain to be a challenging process. To optimize microbial production of single-chain variable fragments (scFvs), we have chosen five model targets, 1) a hapten, Zearalenone (ZEN) mycotoxin, along with infectious...

Descripción completa

Detalles Bibliográficos
Autores principales: Srila, Witsanu, Min, Thae Thae, Sumphanapai, Thitima, Rangnoi, Kuntalee, Berkmen, Mehmet, Yamabhai, Montarop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050041/
https://www.ncbi.nlm.nih.gov/pubmed/36729226
http://dx.doi.org/10.1007/s00253-023-12395-6
_version_ 1785014593966309376
author Srila, Witsanu
Min, Thae Thae
Sumphanapai, Thitima
Rangnoi, Kuntalee
Berkmen, Mehmet
Yamabhai, Montarop
author_facet Srila, Witsanu
Min, Thae Thae
Sumphanapai, Thitima
Rangnoi, Kuntalee
Berkmen, Mehmet
Yamabhai, Montarop
author_sort Srila, Witsanu
collection PubMed
description ABSTRACT: Efficient selection and production of antibody fragments in microbial systems remain to be a challenging process. To optimize microbial production of single-chain variable fragments (scFvs), we have chosen five model targets, 1) a hapten, Zearalenone (ZEN) mycotoxin, along with infectious agents 2) rabies virus, 3) Propionibacterium acnes, 4) Pseudomonas aeruginosa, and a cancer cell 5) acute myeloid leukemia cell line (HL-60). The scFv binders were affinity selected from a non-immunized human phage display scFv antibody library and genetically fused to the N-terminus of emerald green fluorescent protein (EmGFP). The scFv-EmGFP fusion constructs were subcloned into an expression vector, under the control of T7 promoter, C-terminally tagged with hexa-histidine and expressed in different Escherichia coli (E. coli) hosts. This enabled the detection of cells that expressed the correct scFv-EmGFP fusion, termed fluorobody, via bright fluorescent signal in the cytoplasm. Among the three E. coli hosts tested, an engineered E. coli B strain called SHuffle B that promotes disulfide bond formation in the cytoplasm appeared to be the most appropriate host. The recombinant fluorobodies were well expressed (2–8 mg/L), possessed the fluorescence property of EmGFP, and retained the ability to bind to their cognate targets. Their specific bindings were demonstrated by ELISA, fluorescence-linked immunosorbent assay (FLISA), flow cytometry, and fluorescent microscope imaging. The fluorobody expression platform in this study could be further adopted as a one-step immunostaining technique based on scFv, isolated from phage display library to numerous desired targets. KEY POINTS: • E. coli SHuffle express T7 is a suitable expression host for scFv-EmGFP (fluorobody) • Only the clones harboring scFv-EmGFP plasmid will show bright fluorescent signal • This platform can be used to produce fluorobodies for numerous purposes GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-023-12395-6.
format Online
Article
Text
id pubmed-10050041
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-100500412023-03-30 Production and applications of fluorobody from redox-engineered Escherichia coli Srila, Witsanu Min, Thae Thae Sumphanapai, Thitima Rangnoi, Kuntalee Berkmen, Mehmet Yamabhai, Montarop Appl Microbiol Biotechnol Methods and Protocols ABSTRACT: Efficient selection and production of antibody fragments in microbial systems remain to be a challenging process. To optimize microbial production of single-chain variable fragments (scFvs), we have chosen five model targets, 1) a hapten, Zearalenone (ZEN) mycotoxin, along with infectious agents 2) rabies virus, 3) Propionibacterium acnes, 4) Pseudomonas aeruginosa, and a cancer cell 5) acute myeloid leukemia cell line (HL-60). The scFv binders were affinity selected from a non-immunized human phage display scFv antibody library and genetically fused to the N-terminus of emerald green fluorescent protein (EmGFP). The scFv-EmGFP fusion constructs were subcloned into an expression vector, under the control of T7 promoter, C-terminally tagged with hexa-histidine and expressed in different Escherichia coli (E. coli) hosts. This enabled the detection of cells that expressed the correct scFv-EmGFP fusion, termed fluorobody, via bright fluorescent signal in the cytoplasm. Among the three E. coli hosts tested, an engineered E. coli B strain called SHuffle B that promotes disulfide bond formation in the cytoplasm appeared to be the most appropriate host. The recombinant fluorobodies were well expressed (2–8 mg/L), possessed the fluorescence property of EmGFP, and retained the ability to bind to their cognate targets. Their specific bindings were demonstrated by ELISA, fluorescence-linked immunosorbent assay (FLISA), flow cytometry, and fluorescent microscope imaging. The fluorobody expression platform in this study could be further adopted as a one-step immunostaining technique based on scFv, isolated from phage display library to numerous desired targets. KEY POINTS: • E. coli SHuffle express T7 is a suitable expression host for scFv-EmGFP (fluorobody) • Only the clones harboring scFv-EmGFP plasmid will show bright fluorescent signal • This platform can be used to produce fluorobodies for numerous purposes GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-023-12395-6. Springer Berlin Heidelberg 2023-02-02 2023 /pmc/articles/PMC10050041/ /pubmed/36729226 http://dx.doi.org/10.1007/s00253-023-12395-6 Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Methods and Protocols
Srila, Witsanu
Min, Thae Thae
Sumphanapai, Thitima
Rangnoi, Kuntalee
Berkmen, Mehmet
Yamabhai, Montarop
Production and applications of fluorobody from redox-engineered Escherichia coli
title Production and applications of fluorobody from redox-engineered Escherichia coli
title_full Production and applications of fluorobody from redox-engineered Escherichia coli
title_fullStr Production and applications of fluorobody from redox-engineered Escherichia coli
title_full_unstemmed Production and applications of fluorobody from redox-engineered Escherichia coli
title_short Production and applications of fluorobody from redox-engineered Escherichia coli
title_sort production and applications of fluorobody from redox-engineered escherichia coli
topic Methods and Protocols
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050041/
https://www.ncbi.nlm.nih.gov/pubmed/36729226
http://dx.doi.org/10.1007/s00253-023-12395-6
work_keys_str_mv AT srilawitsanu productionandapplicationsoffluorobodyfromredoxengineeredescherichiacoli
AT minthaethae productionandapplicationsoffluorobodyfromredoxengineeredescherichiacoli
AT sumphanapaithitima productionandapplicationsoffluorobodyfromredoxengineeredescherichiacoli
AT rangnoikuntalee productionandapplicationsoffluorobodyfromredoxengineeredescherichiacoli
AT berkmenmehmet productionandapplicationsoffluorobodyfromredoxengineeredescherichiacoli
AT yamabhaimontarop productionandapplicationsoffluorobodyfromredoxengineeredescherichiacoli